In the brain, molecular information is transmitted between cells through neural circuits. Synapses establish connections between the pathways that run from one area to another, allowing the most ...
Sanofi SA gained U.S. FDA approval for fitusiran as a first-in-class siRNA therapy for hemophilia. Branded Qfitlia, the ...
Digital therapeutics coupled with drugs has the potential to transform health care and change the way patients are treated, ...
Immune checkpoint inhibitors (ICIs) are monoclonal antibodies activating the immune system to kill tumor cells, representing a major advancement in cancer treatment. However, by activating T-cell ...
Research published online in Nature on March 19, 2025, closely examines the changes occurring in the gastric epithelium during the progression toward cancer development. Certain mutations that occur ...
It was a mixed day for Daewoong Pharmaceutical Co. Ltd., which disclosed separately on March 28 both the termination of a ...
Researchers from the University of Queensland recently provided details on the discovery and preclinical characterization of ...
Australia’s top universities are looking more to Asia for research collaborations following threats from the Trump ...
In February 2025, BioWorld recorded 148 updates from phase I to phase III trials, marking a decline from the 171 updates tracked in January.
Milestone Pharmaceuticals Inc.’s heart rhythm-restoring calcium channel blocker for paroxysmal supraventricular tachycardia (PSVT) has yet another obstacle in its way.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback